US desire for an alternative to the current multi-shot anthrax vaccine is a boon for delivery systems firm Glide Technologies, which had its contract extended by Pfenex this week.
US biotech Emergent BioSolutions has bought a manufacturing facility from Maryland’s MdBio Foundation is a bid to expand its production infrastructure.
Emergent BioSolutions believes it can reduce its debt, cut operating expenses and gain more flexible production capacity by reorganising its manufacturing operations.
Buoyed by lucrative biodefense contracts, Emergent BioSolutions has
showcased a new large-scale vaccine production facility in Michigan
which it will use to make Biothrax, the only vaccine approved in
the US for the prevention of...